Navigation Links
Arpida Invited to Present Data on Iclaprim at Scientific Conference
Date:4/9/2008

e treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) or healthcare associated pneumonia (HCAP).

In January 2008, the US FDA granted authorisation to progress oral iclaprim into a Phase II 'intravenous-to-oral' switch trial. Iclaprim could be offered not only as an intravenous therapy for hospital use in acute situations, but also as an oral formulation, allowing early patient discharge followed by outpatient treatment. This switch could be a valuable instrument in reducing healthcare costs and enhancing patient comfort.

Arpida's fourth most advanced antibiotic programme, AR-709, targets upper and lower respiratory tract infections acquired in the community setting. AR-709 exhibited potent activity against a large panel of pneumococcal clinical isolates including those resistant to currently used drugs. Promising results of "first-in-man" studies with AR-709 were published in March 2007.

An additional compound, AR-2474, has achieved in vivo proof of concept. AR-2474 has been shown to be effective in eradicating pathogens in preclinical models of skin infection and nasal carriage.

Apart from the antibiotic programmes, Arpida has an innovative antifungal therapy (TLT) which is in Phase III clinical trials in Europe, targeting onychomycosis.

Moreover, the company has several other leads in optimisation and additional discovery programmes derived from its own discovery platform at various research stages.

This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of thes
'/>"/>

SOURCE Arpida Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Women Invited to Join New Health Registry to Advance Research
2. Pharsight Invited to Present on HIV Modeling and Simulation at ASCPT Annual Meeting
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
5. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
10. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
11. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... AMBLER, Pa. , Sept. 29, 2014 /PRNewswire/ ... approval for the CNS Monitor, a medical device ... patients. The CE Mark certifies that a product ... in Europe . ... parameters including electroencephalography (EEG, or brain waves) to ...
(Date:9/29/2014)... , Sept. 29, 2014  Volcano Corporation ... focused on improving patient and economic outcomes on ... minimally invasive coronary and peripheral visualization, physiology diagnostics ... to its Board of Directors from Engaged Capital, ... response:  Volcano welcomes the perspectives ...
(Date:9/29/2014)... NEW YORK , Sept. 29, 2014 /PRNewswire/ ... Summary GlobalData,s new report, "EU5 Sigmoidoscopes Market ... the EU5 Sigmoidoscopes market. The report provides value, ... and average prices (in US dollars) within market ... (Rigid Non-Video Sigmoidoscopes and Flexible Non-Video (Fibre) Sigmoidoscopes). ...
Breaking Medicine Technology:Moberg CNS Monitor Receives European CE Mark Approval for Advanced Neurological Monitoring 2Volcano Issues Statement Regarding Letter From Engaged Capital 2Volcano Issues Statement Regarding Letter From Engaged Capital 3EU5 Sigmoidoscopes Market Outlook to 2020 2EU5 Sigmoidoscopes Market Outlook to 2020 3
... NASHVILLE, Tenn., Aug. 4, 2011 Cumberland Pharmaceuticals Inc. ... has executed a new senior credit agreement with Bank of ... its revolving line of credit to $10 million, which is ... the new facility has been extended to December 2014. ...
... Purdue Pharma, L.P., a privately held pharmaceutical ... International , a U.S.-based humanitarian organization that helps ... view the multimedia assets associated with this release, ... (Photo: http://photos.prnewswire.com/prnh/20110804/MM46982 ) Purdue ...
Cached Medicine Technology:Cumberland Pharmaceuticals Inks New Bank Financing Deal With Bank of America 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 3
(Date:9/29/2014)... (PRWEB) September 30, 2014 NAPW ... Family Therapist at Heaven Sent Consultation , as ... is recognized with this prestigious distinction for leadership in ... organization of professional women in the country, spanning virtually ... Women is a powerfully vibrant networking community with over ...
(Date:9/29/2014)... Top10BestSEOHosting.com is a website dedicated to providing ... is headed by a team of experts and ... information and factual studies about the newest hosting ... , Top10BestSEOHosting.com has recently compared many Linux ... ) and Bluehost are the most recommended suppliers ...
(Date:9/29/2014)... According to the senior spokesman for Fecbek, the oldest ... was worn by a man, Ötzi the Iceman. In ... direction of using small ornamental purses—which evolved into handbags—men's ... leading online supplier of fashion accessories, has released its ... fashionable. , For most men, they do not ...
(Date:9/29/2014)... York, NY (PRWEB) September 29, 2014 ... Some parents get lucky when there little one can slumber ... and takes consistent naps each day. For many parents, the ... perform if you're exhausted and consumed with stress. After ... assumed that like other babies she would fall asleep ...
(Date:9/29/2014)... (PRWEB) September 29, 2014 Dr. Robert ... over 25 years in his hometown, returns to Houston ... Neurosurgical and Spine Center. , Over the last nine ... Army Hospital at Fort Hood and Lubbock. He will ... Neurosurgical Excellence devoted to the goal of excellence in ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Carmel T. Ross, Marriage and Family Therapist at Heaven Sent Consultation, a 2014 Professional Woman of the Year 2Health News:Top10BestSEOHosting.com: New Reviews for Linux Web Hosting Suppliers Available Online 2Health News:Mommy Blogger Offers Advice on Getting Your Baby to Sleep 2Health News:Mommy Blogger Offers Advice on Getting Your Baby to Sleep 3Health News:Houston Neuro & Spine Surgery Plans to Develop Center of Neurosurgical Excellence 2
... of the acclaimed general surgical reference, ACS Surgery, is honored to ... new Editor-in-Chief , ... Philadelphia, PA (PRWEB) March 11, ... reference, ACS Surgery, is honored to announce the appointment of Stanley ...
... 72 hours.,* Health insurance agents and brokers can also receive training ... , ... Chicago, IL (PRWEB) March 11, 2009 -- Norvax ... on Thursday, March 26, just a month after its "standing room ...
... will perform a PPP laser procedure on The Doctors ... for airtime. SANTA CLARA, Calif., March 10 Lumenis ... light-based and radio-frequency devices for surgical, aesthetic, and ophthalmic ... featured on The Doctors national television show on Tuesday, ...
... New research released to mark No Smoking Day (11 ... smokers in Great Britain are thinking,about or planning to cut down ... also shows that one in ten (9%) will be taking the ... No Smoking Day President and Dragons, Den ...
... TUESDAY, March 10 (HealthDay News) -- Used together, a blood ... detecting ovarian cancer in its early and more curable stages, ... a new standard in the fight against this deadly and ... be an approach that may be workable," said Robert Smith, ...
... 2010 state budget maintains charity care spending levelMARLTON, N.J., ... of Virtua Health, praised New Jersey Governor Jon Corzine, ... administration for placing a high priority on the health ... budget that was unveiled today in Trenton.In the state ...
Cached Medicine News:Health News:New Editor, New Vision for ACS Surgery 2Health News:New Editor, New Vision for ACS Surgery 3Health News:Dallas To Host Intensive Norvax University Insurance Agent Sales Training and Web Marketing Conference on March 26 2Health News:Dallas To Host Intensive Norvax University Insurance Agent Sales Training and Web Marketing Conference on March 26 3Health News:Dallas To Host Intensive Norvax University Insurance Agent Sales Training and Web Marketing Conference on March 26 4Health News:Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papules (PPP) Procedure 2Health News:Recession leads 1 in 3 Smokers to cut Down or Quit 2Health News:Recession leads 1 in 3 Smokers to cut Down or Quit 3Health News:Combo of Tests Might Spot Ovarian Cancer Early 2Health News:Combo of Tests Might Spot Ovarian Cancer Early 3Health News:Virtua Commends Gov. Corzine's Charity Care Funding Plan 2
... Total Knee System provides the adaptability surgeons ... patient. Not the other way around. The ... inserts and patellar components allow surgeons to ... you do it all with one instrument ...
... new implant. It's a new material, exclusively ... can be greatly reduced . The nickel ... of the nickel-sensitive patient. Hardness, lubricity and ... is available in our two already proven ...
... TC-PLUS Solution tricompartmental total knee prosthesis stems ... arthroplasty. State-of-the-art design and manufacturing technologies have ... biomechanical function as well as a favorable ... insert to keep wear to a minimum. ...
Cementless hip system...
Medicine Products: